<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04619888</url>
  </required_header>
  <id_info>
    <org_study_id>HeartLogic France Study</org_study_id>
    <nct_id>NCT04619888</nct_id>
  </id_info>
  <brief_title>Follow-up of Heart Failure Patients With an Implantable Cardiac Defibrillator Enabled With the HeartLogic Algorithm - HeartLogic France Study</brief_title>
  <official_title>Follow-up of Heart Failure Patients With an Implantable Cardiac Defibrillator Enabled With the HeartLogic Algorithm - HeartLogic France Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Poitiers University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Poitiers University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Heart Failure (HF) is a chronic disease that leads to numerous rehospitalisations and affects&#xD;
      more than one million people in France.&#xD;
&#xD;
      The main objective of this prospective multicentric French study is to describe the annual&#xD;
      rate of unplanned hospitalisations for heart failure in a cohort of patients managed by a&#xD;
      HeartLogic algorithm.&#xD;
&#xD;
      Patients will be included if they fulfill the following requirements 1/Patient implanted with&#xD;
      a cardiac defibrillator with or without resynchronisation with the HeartLogic index (RESONATE&#xD;
      family, Boston Scientific); 2/History of heart failure (left ventricular ejection fraction&#xD;
      ≤40 %; or at least one episode of clinical heart failure with elevated NT pro BNP≥450 ng/L)&#xD;
&#xD;
      If a HeartLogic index ≥16 is noticed, the investigator will contact the patient to assess the&#xD;
      patient's clinical condition and possibly adjust the heart failure treatment.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 10, 2021</start_date>
  <completion_date type="Anticipated">February 15, 2023</completion_date>
  <primary_completion_date type="Anticipated">February 15, 2023</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Hospitalisation for heart failure</measure>
    <time_frame>During 12 months</time_frame>
    <description>Annual rate of unplanned hospitalisations for heart failure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Annual cardiovascular mortality rate</measure>
    <time_frame>During 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Annual death rate from heart failure</measure>
    <time_frame>During 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Annual rate of unplanned hospitalisation due to ventricular arrhythmia</measure>
    <time_frame>During 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Annual rate of unplanned hospitalisations due to atrial arrhythmia</measure>
    <time_frame>During 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Annual rate of hospitalisation days related to heart failure, ventricular or atrial arrhythmia</measure>
    <time_frame>During 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient quality of life using the Kansas City Cardiomyopathy Questionnaire</measure>
    <time_frame>At baseline and 1 year</time_frame>
    <description>Scale title : KCCQ; Score between 0 and 100; higher scores reflect better health status</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evolution of the average HeartLogic index each week over a 12-month period</measure>
    <time_frame>During 12 months</time_frame>
    <description>Scale title HL index; The lower value is 0 and there is no upper limit; A higher value reflects a higher probability of heart failure</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>HeartLogic cohort</arm_group_label>
    <description>Patients implanted with a defibrillator enabling HeartLogic</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>HeartLogic</intervention_name>
    <description>In case of HeartLogic index ≥16, the investigator will contact the patient to assess the patient's clinical condition and possibly adjust the heart failure treatment. The management will be standardized across centers according to the Manage-HF protocol.</description>
    <arm_group_label>HeartLogic cohort</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Heart failure patients equipped with an ICD&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient implanted with a cardiac defibrillator, with or without resynchronization,&#xD;
             enabled with the HeartLogic index (RESONATE family, Boston Scientific)&#xD;
&#xD;
          -  History of heart failure (left ventricular ejection fraction ≤40 %; or at least one&#xD;
             episode of clinical heart failure with elevated NT pro BNP≥450 ng/L)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Concomitant presence of a heart failure device other than cardiac resynchronisation&#xD;
             such as a left ventricular assist device or a device for modulating cardiac&#xD;
             contractility.&#xD;
&#xD;
          -  Heart transplant project, or heart transplant patient&#xD;
&#xD;
          -  Glomerular filtration rate &lt;30 ml/mn/m2 or dialysis,&#xD;
&#xD;
          -  Life expectancy ≤ 6 months&#xD;
&#xD;
          -  Remote monitoring of HeartLogic is not possible.&#xD;
&#xD;
          -  Refusal to take medication for heart failure&#xD;
&#xD;
          -  Patient with a mechanical heart valve&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rodrigue Garcia</last_name>
    <role>Study Director</role>
    <affiliation>University hospital of Poitiers</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rodrigue Garcia</last_name>
    <phone>+33549444444</phone>
    <email>celine.deletage-metreau@chu-poitiers.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Celine Deletage</last_name>
    <phone>+33549444444</phone>
    <email>celine.deletage-metreau@chu-poitiers.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University hospital of Brest</name>
      <address>
        <city>Brest</city>
        <zip>29200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacques Mansourati</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital of Lorient</name>
      <address>
        <city>Lorient</city>
        <zip>56100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pierre Khattar</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique du Confluent</name>
      <address>
        <city>Nantes</city>
        <zip>44000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Gras</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Europeen G Pompidou</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Eloi Marijon</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique Pasteur</name>
      <address>
        <city>Toulouse</city>
        <zip>33000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Serge Boveda</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>November 2, 2020</study_first_submitted>
  <study_first_submitted_qc>November 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 6, 2020</study_first_posted>
  <last_update_submitted>March 15, 2021</last_update_submitted>
  <last_update_submitted_qc>March 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Implantable cardioverter defibrillator</keyword>
  <keyword>quality of life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

